A weight loss plateau happens when weight loss stops despite continued efforts
Improvements in visceral adiposity exceeded those observed in the comparator group receiving a sodium-glucose cotransporter 2 (SGLT2) inhibitor
Tirzepatide versus dulaglutide Among patients in the expanded population who initiated tirzepatide or dulaglutide, the 1-year risk for the primary endpoint including all-cause mortality in the tirzepatide group was 1.4% (95% CI 1.3% to 1.6%) versus 1.8% (95% CI 1.5% to 2.0%) for dulaglutide
To perform Na + dependence assays, carnitine doses were applied to oocytes expressing hOCTN2, and related mutants, in the presence of Cl - buffers of differing Na + concentration (10100 mM NaCl, 100 mM - [NaCl] CsCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES, buffered to pH 7.4 with Tris base)
Stem cell senescence also depends on gene expression and microenvironmental cues